Last reviewed · How we verify
PlexoZome® Levagen® topical spray solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
PlexoZome® Levagen® topical spray solution (PlexoZome® Levagen® topical spray solution) — RDC Clinical Pty Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PlexoZome® Levagen® topical spray solution TARGET | PlexoZome® Levagen® topical spray solution | RDC Clinical Pty Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PlexoZome® Levagen® topical spray solution CI watch — RSS
- PlexoZome® Levagen® topical spray solution CI watch — Atom
- PlexoZome® Levagen® topical spray solution CI watch — JSON
- PlexoZome® Levagen® topical spray solution alone — RSS
Cite this brief
Drug Landscape (2026). PlexoZome® Levagen® topical spray solution — Competitive Intelligence Brief. https://druglandscape.com/ci/plexozome-levagen-topical-spray-solution. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing